Family history of prostate cancer does not affect outcomes of seed implant therapyJanuary 3rd, 2009 - 4:56 pm ICT by ANI
Washington, January 3 (ANI): A new study has revealed that a first-degree family history of prostate cancer does not have any impact on the treatment outcomes of patients treated with brachytherapy, also known as seed implants.
Reproted in the International Journal of Radiation OncologyBiology Physics, the study has also shown that patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all.
“This information is relevant for both physicians and patients with new diagnoses as they embark on complex treatment decisions,” Dr. Christopher A. Peters, a radiation oncologist at Northeast Radiation Oncology Center in Dunmore, Pa., who was chief resident at Mount Sinai School of Medicine at the time of the study, said.
“Now patients with a family history of prostate cancer can be confident that they have the same outcomes as patients with sporadic disease, regardless of the treatment modality they chose,” added the lead author of the study.
In the study, the researchers sought to determine if having a familial history of prostate cancer, which is defined as a clustering of prostate cancer cases within a family, had an impact on the prognosis of men treated with brachytherapy for clinically localized prostate cancer patients.
The team followed 1,738 prostate cancer patients, of which 187 had a family history of prostate cancer in a first-degree relative, for a median follow-up time of 60 months.
The researchers observed that in the low-, intermediate- and high-risk groups, a family history of prostate cancer had little to no prognostic significance in men treated with brachytherapy.
They pointed out that previous studies done with prostate cancer patients receiving external beam radiation therapy or radical prostatectomy also had similar findings. (ANI)
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- 'Watchful waiting' often best strategy for low-risk prostate cancer - Jun 19, 2010
- Genetic markers could help detect early prostate cancer onset - Jun 08, 2010
- Prostate cancer screening improves patients' quality of life - Oct 26, 2010
- Hormone therapy ups death risk for prostate cancer patients with heart disease - Aug 26, 2009
- Prostate cancer patients who remain disease free for 5yrs after treatment less likely to have recurr - Jul 03, 2009
- Seed implants suitable treatment option for prostate cancer patients of all ages - Aug 04, 2009
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
- Aspirin use 'cuts risk of death from prostate cancer by more than half' - Oct 26, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- Smoking and radiation therapy for head, neck cancers don't mix - Nov 17, 2010
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Chemo-radiation combo may avert prostate cancer recurrence - Nov 05, 2009
- Blood vessels could predict how prostate cancer would behave - Nov 04, 2009
- Exercise improves survival in prostate cancer patients - Feb 02, 2012
Tags: dunmore pa, external beam radiation, familial history, history of prostate cancer, mount sinai school, mount sinai school of medicine, prognostic significance, prostate cancer, prostate cancer cases, prostate cancer patients, radiation oncologist, radiation oncology center, radiation therapy, radical prostatectomy, risk groups, seed implant therapy, seed implants, sporadic disease, treatment decisions, treatment modality